HOME
TEAM
PUBLICATIONS
EVENTS
RESOURCES
ACKNOWLEDGEMENTS
JOIN US

EN
CN

Longitudinal Serum Proteomics Characterization of CD19-CAR-T Cell Therapy for B-Cell Malignancies

Longitudinal Serum Proteomics Characterization of CD19-CAR-T Cell Therapy for B-Cell Malignancies

1 Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China.

2 Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China.

3 Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.

Wechat:

Westlake University
www.westlake.edu.cn
Westlake Center for Intelligent Proteomics
www.we-cip.com
Westlake Omics
www.westlakeomics.com
π-hub
www.pi-hub.org.cn
HUPO
www.hupo.org
CNHUPO
cnhupo.org.cn

©2021 Guomics Laboratory